The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here:

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

The mission

The overarching goal for the Molecular Neuromodulation team is to bring together frontline gene-based technologies with in vivo gene transfer, behavioral and cognitive assessments in disease models of Parkinson’s disease and related disorders for the development of clinical therapies for tomorrow. 

Towards this ultimate goal, the team works along three major areas of research, briefly outlined  in the lnks below.